Prednisone (Deltasone, Rayos, Prednisone Intensol)

Other Medications · Approved since 1955

US FDA Approved EU EMA Approved ES Hospital use other indication Oral 3 Clinical Trials
Glucocorticoid receptor

Description

Prednisone is a synthetic corticosteroid medication used in colorectal cancer treatment primarily as supportive care to manage immune-related adverse events, particularly severe colitis caused by immune checkpoint inhibitors. It serves as an anti-inflammatory and immunosuppressive agent to control treatment-related complications rather than directly treating the cancer itself. Prednisone may also be used as premedication to prevent allergic reactions to certain chemotherapy agents or to manage other inflammatory conditions that arise during cancer treatment.

Mechanism of Action

Prednisone acts as a glucocorticoid receptor agonist, binding to cytoplasmic glucocorticoid receptors and forming complexes that translocate to the nucleus to regulate gene transcription. This mechanism suppresses inflammatory cytokine production, reduces T-cell activation, and decreases immune system activity, making it effective for treating immune checkpoint inhibitor-induced colitis and other inflammatory complications of cancer therapy.

Molecular Targets

Side Effects

Increased appetite and weight gain Mood changes and irritability Elevated blood glucose levels Increased infection risk Fluid retention and swelling Insomnia Stomach upset and peptic ulcers Bone loss with long-term use

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT03819296 Phase 1
Recruiting
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
United States
NCT07620574 Phase 3
Not yet recruiting
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
NCT04305145 Phase 2
Active, not recruiting
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
United States